NYSE: LLYEli Lilly and Company

HealthcareMkt Cap $1.02TCongress ownership rank #65

Eli Lilly and Company Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 227 trades in Eli Lilly and Company (NYSE: LLY) since 2013, across 50 members, worth an estimated $7.1M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 113 buys against 114 sells, a modestly sell-led skew, with Democratic members responsible for 65% of the trades and Republican members 35%. The most recent disclosure shown was filed May 2026, and David J. Taylor has filed the most LLY transactions among those shown, with 6. Other recent filers include Elizabeth Fletcher, Byron Donalds, and Gilbert Cisneros. One notable disclosed move was a purchase by John Boozman on August 11, 2025, up 79.6% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Eli Lilly and Company (LLY) stock overview and the complete trade table below.